Takemasa Sakaguchi Selected Research

Takemasa Sakaguchi Research Topics

Disease

14	Infections 09/2022 - 09/2003
6	Vesicular Stomatitis 01/2021 - 01/2005
5	COVID-19 07/2022 - 01/2021
4	Neoplasms (Cancer) 11/2020 - 05/2011
3	Virus Diseases (Viral Diseases) 01/2022 - 05/2008
3	Osteosarcoma (Osteogenic Sarcoma) 11/2020 - 05/2011
3	Human Influenza (Influenza) 01/2019 - 05/2015
3	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2002
3	Melanoma (Melanoma, Malignant) 07/2012 - 11/2011
2	Influenza in Birds (Avian Flu) 09/2022 - 01/2018
2	Keratitis 08/2021 - 01/2021
2	Acanthamoeba Keratitis 01/2021 - 12/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2017 - 11/2015
1	Common Cold 01/2022
1	Acute Promyelocytic Leukemia 01/2021
1	Edema (Dropsy) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Paramyxoviridae Infections (Parainfluenza) 01/2021
1	Cysts 12/2019
1	Blindness (Hysterical Blindness) 12/2019
1	Necrosis 12/2019
1	Circulating Neoplastic Cells 01/2018
1	Mumps 09/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2011
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 10/2011
1	Atherosclerotic Plaque (Atheroma) 01/2007
1	Hyperplasia 01/2007

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
5	RNA (Ribonucleic Acid)IBA 01/2018 - 05/2008
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2015
4	InterferonsIBA 01/2019 - 05/2010
3	chlorinIBA 08/2021 - 12/2019
3	TONS504IBA 08/2021 - 12/2019
2	PotassiumIBA 09/2022 - 01/2018
2	15- methyl- 8- aza- 16- oxagona- 1,3,5(10),13- tetraen- 17- one (MAOTO)IBA 01/2022 - 01/2019
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 12/2019
2	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 12/2019
2	VaccinesIBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
2	Viral RNAIBA 01/2018 - 01/2015
2	Interferon-betaIBA 01/2018 - 07/2012
2	LectinsIBA 05/2015 - 01/2007
2	Sendai virus V proteinIBA 11/2011 - 09/2003
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2022
1	SaltsIBA 09/2022
1	casirivimab and imdevimab drug combinationIBA 07/2022
1	Ephedrae herbaIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	6-formylindolo(3,2-b)carbazoleIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	EnzymesIBA 01/2021
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	H 77IBA 01/2021
1	Ophthalmic Solutions (Eye Drops)IBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	SmokeIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 11/2020
1	ethidium homodimerIBA 12/2019
1	isothiocyanic acidIBA 12/2019
1	Annexin A5IBA 12/2019
1	Trypan Blue FDA Link 12/2019
1	kakkon-toIBA 01/2019
1	Oleic Acid (Oleate)IBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018
1	Interferon Type IIBA 01/2018
1	LigandsIBA 01/2018
1	Soaps (Soap)IBA 01/2018
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	STAT1 Transcription FactorIBA 11/2015
1	Interferon-alpha (Interferon Alfa)IBA 11/2015
1	Mannose (D-Mannose)IBA 05/2015
1	TanninsIBA 01/2013
1	Bone Marrow Stromal Antigen 2IBA 09/2012
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2011
1	NF-kappa B (NF-kB)IBA 10/2011
1	GTP-Binding Proteins (G-Protein)IBA 05/2011
1	Messenger RNA (mRNA)IBA 05/2010
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2007
1	oxidized low density lipoproteinIBA 01/2007
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2005
1	asialo GM1 gangliosideIBA 08/2002
1	AntibodiesIBA 08/2002
1	Interleukin-2 (IL2)IBA 08/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2019
2	Kampo Medicine (Kampo) 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Contact Lenses 01/2021
1	Injections 01/2018
1	Precision Medicine 01/2018
1	Intravenous Infusions 02/2013
1	Oncolytic Virotherapy 05/2011